In conclusion, mitral valve repair using the MitraClip percutaneous technique is feasible and safe in high risk, mainly
inoperable, highly symptomatic patients with significant
MR. Acute and mid-term improvement in MR grade and
functional class were observed in our cohort. These results
are comparable to similar high risk patient cohorts in the
literature. Continued surveillance and longer follow-up are
needed to elucidate which patients are most likely to benefit
from the procedure